electroCore Stock (NASDAQ:ECOR)
Previous Close
$4.88
52W Range
$4.16 - $19.49
50D Avg
$5.05
200D Avg
$7.76
Market Cap
$38.23M
Avg Vol (3M)
$70.63K
Beta
0.34
Div Yield
-
ECOR Company Profile
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.